Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force

Keyphrases

• US Preventive Services Task Force (USPSTF) 100%
• Adverse Effects 100%
• Breast Cancer 100%
• Ovarian Cancer Screening 100%
• Breast Cancer Susceptibility 100%
• Systematic Evidence Review 100%
• Genetic Risk Assessment 100%
• BRCA Testing 100%
• Risk Reduction 66%
• Ovarian Cancer 66%
• Genetic Counseling 66%
• Mutation Testing 66%
• Risk Assessment 66%
• Selected Populations 66%
• Inherited Breast Cancer 66%
• MEDLINE 33%
• United States 33%
• Primary Care Setting 33%
• Primary Care 33%
• Genetic Heterogeneity 33%
• Potential Adverse Effects 33%
• Data Extraction 33%
• Data Synthesis 33%
• Risk Perception 33%
• Mutation Carriers 33%
• Statistical Methods 33%
• Screening Study 33%
• Preventive Intervention 33%
• Increased Vulnerability 33%
• Cochrane Library 33%
• Library Databases 33%
• Genetic mutation 33%
• Cancer Screening 33%
• Exclusion Criteria 33%
• Psychosocial Outcomes 33%
• BRCA mutation 33%
• Risk Level 33%
• Chemoprevention Trial 33%
• BRCA2 Gene 33%
• Mutation-genetics 33%
• Heterogeneity Factor 33%
• BRCA1 Gene 33%
• Referral Guidelines 33%
• Primary Care Approach 33%
• Psychological Counseling 33%
• Moderating Factors 33%
• Descriptive Method 33%
• Public Interest 33%
• Prophylactic Surgery 33%
• Evidence Tables 33%
• Assessing Risks 33%
• Accuracy Effect 33%
• Clinically Significant mutations 33%
• Synthesis Tools 33%

Medicine and Dentistry

• Ovarian Cancer 100%
• Genetic Risk 100%
• BRCA Mutation 100%
• Adverse Effect 80%
• Primary Health Care 60%
• Genetic Counseling 40%
• Risk Reduction 20%
• Observational Study 20%
• Malignant Neoplasm 20%
• Gene Mutation 20%
• Patient Referral 20%
• Breast Cancer 20%
• Counseling 20%
• Tumor Suppressor Gene 20%
• Genetic Heterogeneity 20%
• BRCA1 20%
• Risk Perception 20%
• Chemoprophylaxis 20%
• Psychological Outcome 20%
• Cancer Screening 20%